Genetic secrets of long-term glioblastoma survivors

le Jovčevska, Ivana
Foilsithe in Bosn J Basic Med Sci (2019)

Next Generation Sequencing and Machine Learning Technologies Are Painting the Epigenetic Portrait of Glioblastoma

le Jovčevska, Ivana
Foilsithe in Front Oncol (2020)

The Therapeutic Potential of Nanobodies

le Jovčevska, Ivana, Muyldermans, Serge
Foilsithe in BioDrugs (2019)

Glioma and glioblastoma - how much do we (not) know?

le JOVČEVSKA, IVANA, KOČEVAR, NINA, KOMEL, RADOVAN
Foilsithe 2013

Nanotechnology Meets Oncology: Nanomaterials in Brain Cancer Research, Diagnosis and Therapy

le Zottel, Alja, Videtič Paska, Alja, Jovčevska, Ivana
Foilsithe in Materials (Basel) (2019)

Nanomedicine and Immunotherapy: A Step Further towards Precision Medicine for Glioblastoma

le Šamec, Neja, Zottel, Alja, Videtič Paska, Alja, Jovčevska, Ivana
Foilsithe in Molecules (2020)

Coding of Glioblastoma Progression and Therapy Resistance through Long Noncoding RNAs

le Zottel, Alja, Šamec, Neja, Videtič Paska, Alja, Jovčevska, Ivana
Foilsithe in Cancers (Basel) (2020)

High FREM2 Gene and Protein Expression Are Associated with Favorable Prognosis of IDH-WT Glioblastomas

le Jovčevska, Ivana, Zottel, Alja, Šamec, Neja, Mlakar, Jernej, Sorokin, Maxim, Nikitin, Daniil, Buzdin, Anton A., Komel, Radovan
Foilsithe in Cancers (Basel) (2019)

Anti-vimentin, anti-TUFM, anti-NAP1L1 and anti-DPYSL2 nanobodies display cytotoxic effect and reduce glioblastoma cell migration

le Zottel, Alja, Jovčevska, Ivana, Šamec, Neja, Mlakar, Jernej, Šribar, Jernej, Križaj, Igor, Skoblar Vidmar, Marija, Komel, Radovan
Foilsithe in Ther Adv Med Oncol (2020)

Meta-Analysis and Experimental Validation Identified FREM2 and SPRY1 as New Glioblastoma Marker Candidates

le Vidak, Marko, Jovcevska, Ivana, Samec, Neja, Zottel, Alja, Liovic, Mirjana, Rozman, Damjana, Dzeroski, Saso, Juvan, Peter, Komel, Radovan
Foilsithe in Int J Mol Sci (2018)

Glioblastoma-specific anti-TUFM nanobody for in-vitro immunoimaging and cancer stem cell targeting

le Samec, Neja, Jovcevska, Ivana, Stojan, Jure, Zottel, Alja, Liovic, Mirjana, Myers, Michael P., Muyldermans, Serge, Šribar, Jernej, Križaj, Igor, Komel, Radovan
Foilsithe in Oncotarget (2018)

Differentially expressed proteins in glioblastoma multiforme identified with a nanobody-based anti-proteome approach and confirmed by OncoFinder as possible tumor-class predictive...

le Jovčevska, Ivana, Zupanec, Neja, Urlep, Žiga, Vranič, Andrej, Matos, Boštjan, Stokin, Clara Limbaeck, Muyldermans, Serge, Myers, Michael P., Buzdin, Anton A., Petrov, Ivan, Komel, Radovan
Foilsithe in Oncotarget (2017)

Large-Scale Transcriptomics-Driven Approach Revealed Overexpression of CRNDE as a Poor Survival Prognosis Biomarker in Glioblastoma

le Sorokin, Maxim, Raevskiy, Mikhail, Zottel, Alja, Šamec, Neja, Skoblar Vidmar, Marija, Matjašič, Alenka, Zupan, Andrej, Mlakar, Jernej, Suntsova, Maria, Kuzmin, Denis V., Buzdin, Anton, Jovčevska, Ivana
Foilsithe in Cancers (Basel) (2021)

Analysis of miR-9-5p, miR-124-3p, miR-21-5p, miR-138-5p, and miR-1-3p in Glioblastoma Cell Lines and Extracellular Vesicles

le Zottel, Alja, Šamec, Neja, Kump, Ana, Dall’Olio, Lucija Raspor, Pužar Dominkuš, Pia, Romih, Rok, Hudoklin, Samo, Mlakar, Jernej, Nikitin, Daniil, Sorokin, Maxim, Buzdin, Anton, Jovčevska, Ivana, Komel, Radovan
Foilsithe in Int J Mol Sci (2020)

TRIM28 and β-Actin Identified via Nanobody-Based Reverse Proteomics Approach as Possible Human Glioblastoma Biomarkers

le Jovčevska, Ivana, Zupanec, Neja, Kočevar, Nina, Cesselli, Daniela, Podergajs, Neža, Stokin, Clara Limbaeck, Myers, Michael P., Muyldermans, Serge, Ghassabeh, Gholamreza Hassanzadeh, Motaln, Helena, Ruaro, Maria Elisabetta, Bourkoula, Evgenia, Turnšek, Tamara Lah, Komel, Radovan
Foilsithe in PLoS One (2014)

Advances in Molecular Genetics of Brain Tumors

Foilsithe 2023

Advances in Molecular Genetics of Brain Tumors

Foilsithe 2023